Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 17:27
Lakefront Biotherapeutics Price to Book Value : 0.5195 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 0.5279 |
| October 06, 2026 | 0.5159 |
| October 05, 2026 | 0.5193 |
| October 02, 2026 | 0.5168 |
| October 01, 2026 | 0.5078 |
| September 30, 2026 | 0.5217 |
| September 29, 2026 | 0.5194 |
| September 28, 2026 | 0.5251 |
| September 25, 2026 | 0.517 |
| September 24, 2026 | 0.5342 |
| September 23, 2026 | 0.5405 |
| September 22, 2026 | 0.5312 |
| September 21, 2026 | 0.5207 |
| September 18, 2026 | 0.5024 |
| September 17, 2026 | 0.5087 |
| September 16, 2026 | 0.4844 |
| September 15, 2026 | 0.4913 |
| September 14, 2026 | 0.47 |
| September 11, 2026 | 0.4717 |
| September 10, 2026 | 0.4717 |
| September 09, 2026 | 0.4827 |
| September 08, 2026 | 0.4862 |
| September 04, 2026 | 0.5013 |
| September 03, 2026 | 0.5106 |
| September 02, 2026 | 0.5069 |
| Date | Value |
|---|---|
| September 01, 2026 | 0.5024 |
| August 31, 2026 | 0.5015 |
| August 28, 2026 | 0.5082 |
| August 27, 2026 | 0.518 |
| August 26, 2026 | 0.5131 |
| August 25, 2026 | 0.5226 |
| August 24, 2026 | 0.511 |
| August 21, 2026 | 0.5068 |
| August 20, 2026 | 0.4974 |
| August 19, 2026 | 0.5166 |
| August 18, 2026 | 0.4925 |
| August 17, 2026 | 0.4842 |
| August 14, 2026 | 0.4844 |
| August 13, 2026 | 0.4934 |
| August 12, 2026 | 0.4914 |
| August 11, 2026 | 0.5055 |
| August 10, 2026 | 0.4735 |
| August 07, 2026 | 0.4751 |
| August 06, 2026 | 0.4598 |
| August 05, 2026 | 0.4589 |
| August 04, 2026 | 0.4654 |
| August 03, 2026 | 0.4705 |
| July 31, 2026 | 0.4788 |
| July 30, 2026 | 0.4863 |
| July 29, 2026 | 0.4878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.43 |
| ACADIA Pharmaceuticals, Inc. | 2.578 |
| Alkermes Plc | 3.716 |
| Alnylam Pharmaceuticals, Inc. | 22.17 |
| Amarin Corp. Plc | 0.5686 |
Price to Book Value Related Metrics
| PE Ratio | 2.805 |
| PS Ratio | 1.714 |
| Price | 29.52 |
| Earnings Yield | 35.65% |
| Market Cap | 1.938B |
| Operating PE Ratio | 2.878 |
| Normalized PE Ratio | 2.211 |